Search results for "Cardiovascular Disease"
Cytisinicline shows promise for smoking cessation in industry-funded trial
In a phase 3 randomized controlled trial, both six- and 12-week courses of cytisinicline, an investigational drug, led to higher rates of continuous smoking abstinence compared with placebo.
https://immattersacp.org/weekly/archives/2023/07/18/1.htm
18 Jul 2023
A1c predicts cardiovascular disease, death in nondiabetics
A1c predicts cardiovascular disease, death in nondiabeticsGuidelines suggest more informed consent for prostate cancer screening
https://immattersacp.org/weekly/archives/2010/03/09/1.htm
9 Mar 2010
Individualize behavioral counseling in those without CVD risk factors, USPSTF says
In an update consistent with its 2017 recommendation, the U.S. Preventive Services Task Force (USPSTF) recommended that clinicians individualize the use of behavioral counseling interventions to promote a healthy diet and physical activity in adults without risk factors for cardiovascular disease (CVD).
https://immattersacp.org/weekly/archives/2022/08/02/4.htm
2 Aug 2022
MKSAP Quiz: Motivating lifestyle change
A 28-year-old man is evaluated during a follow-up visit for hypertension and diabetes mellitus. He works two jobs and eats fast food for most meals. Which of the following is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/03/21/3.htm
21 Mar 2023
Discontinuing primary preventive aspirin didn't appear to increase mortality risk
Regular aspirin users who were switched to placebo in a randomized trial did not have increased risk of all-cause mortality or cardiovascular disease events compared with those who continued aspirin, but the findings of the post hoc analysis were inconclusive.
https://immattersacp.org/weekly/archives/2022/03/15/2.htm
15 Mar 2022
MKSAP Quiz: Follow-up for systemic lupus erythematosus
A 30-year-old woman is seen in follow-up. She was diagnosed with systemic lupus erythematosus 12 years ago. She was treated for lupus nephritis, which is now quiescent. What health risk assessment should be performed now?
https://immattersacp.org/weekly/archives/2022/04/05/3.htm
5 Apr 2022
Nonsugar sweeteners should not be used for weight loss, WHO guideline states
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
https://immattersacp.org/weekly/archives/2023/05/23/2.htm
23 May 2023
Low-dose aspirin associated with 20% increase in risk of anemia among older adults
Analysis of a randomized trial of aspirin in healthy older patients found significantly increased risk of anemia, faster decline in hemoglobin concentrations, and greater decline in ferritin levels with aspirin versus placebo.
https://immattersacp.org/weekly/archives/2023/06/20/1.htm
20 Jun 2023
USPSTF pulls back on recommendation of low-dose aspirin for primary prevention
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) now recommends against initiating low-dose aspirin for the primary prevention of cardiovascular disease in adults ages 60 years or older and says use should be an individual decision in patients ages 40 to 59 years.
https://immattersacp.org/weekly/archives/2021/10/19/5.htm
19 Oct 2021
Temporary weight management programs may have long-term cardiometabolic benefits
Trial participants who completed behavioral weight management programs had long-term reductions in systolic blood pressure, cholesterol levels, and HbA1c level relative to comparators, but weight regain reduced these differences over time, a systematic review and meta-analysis found.
https://immattersacp.org/weekly/archives/2023/04/04/2.htm
4 Apr 2023